---
title: "BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, R... — FDA record Z-2458-2024 | Is It on Recall"
description: "Catheters may contain a hole in the catheter tubing, which could result in leakage during the insertion process."
url: https://isitonrecall.com/recall/fda-device-z-2458-2024-bd-insyte-autoguard-bc-shielded-iv-catheter-with-blood-control-technology-ref-382533-20-ga-x-1-00-in/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA device enforcement

# BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF: 382533, 20 GA x 1.00 in (1.1x25 mm) ... — FDA record Z-2458-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 26, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF: 382533, 20 GA x 1.00 in (1.1x25 mm) 63 mL/min, Rx Only. BD Insyte Autoguard BC Shielded IV Catheter is intended to be inserted into a patient's peripheral vascular system for short term use to sample blood, monitor blood pressure, or administer fluids.
- **Reason**: Catheters may contain a hole in the catheter tubing, which could result in leakage during the insertion process.
- **Classification**: Class II
- **Recalling firm**: Becton Dickinson Infusion Therapy Systems, Inc.
- **Quantity**: 26,400 units
- **Agency-reported status**: Ongoing
- **Source record identifier**: Z-2458-2024

[Open the official record](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2458-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # 4127714/ UDI-DI: 00382903825332 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

US: IL OUS: N/A0

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Illinois](https://isitonrecall.com/state/illinois/)

## Dates in the source

- **Report date**: Aug 7, 2024
- **Recall initiation date**: Jun 26, 2024
- **Center classification date**: Jul 31, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2458-2024%22)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [Becton Dickinson Infusion Therapy Systems Inc. records](https://isitonrecall.com/brand/becton-dickinson-infusion-therapy-systems-inc/)